John Menditto | VP, IR and Corporate Communications |
Dave Mazzo | CEO |
David Slack | President and Chief Business Officer |
James Nisco | VP, Finance and Treasury |
Kristen Buck | EVP, Research and Development and Chief Medical Officer |
Peter Enderlin | MAZ Partners |
Shubhendu Roy | Brooklyn Capital Markets |
Welcome to the Lisata Therapeutics Third Quarter 2022 Financial Results and Business Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, Thursday, November 10, 2022. I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Lisata. Please go ahead, sir.
Thank you, operator, and good afternoon, everyone.